Codice QR

One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study

Introduction: The impact of ETI therapy on pulmonary function and nutritional status has been widely studied; the literature on the possible outcomes on glycemic control and insulin requirement in patients affected by CFRD is controversial. Aim: The main objective of our study was to evaluate HbA1c...

Descrizione completa

Salvato in:
Autori principali: Marta Bassi, Marina Francesca Strati, Gaia Spiandorello, Marta Scalas, Federico Cresta, Maria Grazia Calevo, Giuseppe d’Annunzio, Carlo Castellani, Nicola Minuto, Mohamad Maghnie, Rosaria Casciaro
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2024-10-01
Serie:Life
Soggetti:
CFRD
cystic fibrosis
diabetes
CFTR modulators
ETI treatment
Accesso online:https://www.mdpi.com/2075-1729/14/10/1309
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi